BIO Historical Earnings image   This BIO historical earnings page last updated 10/31/2022
BIO Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202210/27/20220.68B
Q2 20227/28/20220.69B
Q1 20224/28/20220.70B
Q4 20212/10/20220.73B
Q3 202110/28/20210.72B
Q2 20217/29/20210.72B
Q1 20214/29/20210.73B
Q4 20202/11/20210.79B
Q3 202010/29/20200.65B
Q2 20207/30/20200.54B
Q1 20205/6/20200.57B
Q4 20192/13/20200.62B
Q3 201910/31/20190.56B
Q2 20198/1/20190.57B
Q1 20195/8/20190.55B
Q4 20182/28/2019617.54M
Q3 201811/1/2018545.14M
Q2 20188/7/2018575.91M
Q1 20185/8/2018551.52M
Q4 20172/27/2018620.43M
Q3 201711/2/2017535.00M
Q2 20178/3/2017504.67M
Q1 20175/4/2017500.05M
Q4 20162/23/2017571.45M
Q3 201611/1/2016508.75M
Q2 20168/3/2016516.78M
Q1 20165/5/2016471.20M
Q4 20152/25/2016570.56M
Q3 201511/3/2015469.96M
Q2 20158/6/2015506.10M
Q1 20155/5/2015472.80M
Q4 20142/26/2015598.22M
Q3 201411/4/2014530.60M
Q2 20148/5/2014536.80M
Q1 20145/6/2014509.34M
Q4 20132/27/2014602.60M
Q3 201311/7/2013505.10M
Q2 20138/6/2013525.30M
Q1 20135/7/2013499.70M
Q4 20122/26/2013573.80M
Q3 201211/6/2012498.70M
Q2 20128/7/2012510.42M
Q1 20125/1/2012486.28M
BIO Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q3 202210/27/20222.600
Q2 20227/28/20223.380
Q1 20224/28/20224.940
Q4 20212/10/20223.210
Q3 202110/28/20213.710
Q2 20217/29/20213.540
Q1 20214/29/20215.210
Q4 20202/11/20214.010
Q3 202010/29/20203.000
Q2 20207/30/20201.610
Q1 20205/6/20201.910
Q4 20192/13/20202.320
Q3 201910/31/20191.610
Q2 20198/1/20191.570
Q1 20195/8/20191.650
Q4 20182/28/20192.13
Q3 201811/1/20180.91
Q2 20188/7/20181.64
Q1 20185/8/20181.17
Q4 20172/27/20181.5
Q3 201711/2/20170.91
Q2 20178/3/20170.17
Q1 20175/4/20170.62
Q4 20162/23/20170.78
Q3 201611/1/20160.62
Q2 20168/3/20161.02
Q1 20165/5/20160.42
Q4 20152/25/20161.68
Q3 201511/3/20150.59
Q2 20158/6/20151.12
Q1 20155/5/20150.61
Q4 20142/26/20151.34
Q3 201411/4/20140.39
Q2 20148/5/20141.09
Q1 20145/6/20140.23
Q4 20132/27/20141.04
Q3 201311/7/2013-0.25
Q2 20138/6/20131.2
Q1 20135/7/20130.68
Q4 20122/26/20131.65
Q3 201211/6/20121.48
Q2 20128/7/20121.69
Q1 20125/1/20121.09
Quotes delayed 20 minutes

Email EnvelopeFree BIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Bio-Rad Laboratories (BIO) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

BIOC Historical Earnings
BIOL Historical Earnings
BIOR Historical Earnings
BIVI Historical Earnings
BKD Historical Earnings
BLCM Historical Earnings
BLFS Historical Earnings
BLI Historical Earnings
BLPH Historical Earnings
BLUE Historical Earnings
What was the record high BIO historical earnings result?
In terms of earnings or revenue, what is the best BIO historical earnings result that Bio-Rad Laboratories has ever posted, and when?

✔️Accepted answer: Within our data set, the highest BIO historical earnings result was set in Q1 2021, when Bio-Rad Laboratories posted results of 5.210/share. The most successful revenue quarter within our data set was Q4 2020 when Bio-Rad Laboratories reported revenue of 0.79B.

What was the lowest Bio-Rad Laboratories historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest BIO has reported, and when?

✔️Accepted answer: Within our data set, the lowest BIO historical earnings result was set in Q3 2013, when Bio-Rad Laboratories posted results of -0.25/share. The smallest revenue quarter within our data set was Q3 2015 when Bio-Rad Laboratories reported revenue of 469.96M.

On this page we presented the BIO historical earnings date information for Bio-Rad Laboratories. Reviewing that BIO Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q1 2021, when BIO posted adjusted EPS of 5.210/share. Meanwhile the lowest BIO historical earnings result was in Q3 2013, when BIO posted adjusted EPS of -0.25/share. Moving to Bio-Rad Laboratoriess historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2020 when BIO reported 0.79B in revenue, while the smallest revenue quarter was Q3 2015 when BIO reported 469.96M in revenue.

For self directed investors doing their due diligence on BIO or any other given stock, their research can benefit from looking into all of the Bio-Rad Laboratories historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Bio-Rad Laboratories historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for BIO. Thanks for visiting, and the next time you need to research BIO historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: COWN shares outstanding history, Top Ten Hedge Funds Holding OPEN, HLI market cap history.

 

BIO Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.